Jump to main content
Jump to site search

Multiple Single Cell Screening and DNA MDA Amplification Chip for Oncogenic Mutation Profiling


The oncogenic mutation heterogeneity of the cancer cell population has been proved essential for predicting both drug-response and drug-resistance of targeted therapies, such as tyrosine kinase inhibitors. To accurately evaluate the mutation heterogeneity, oncogenic/resistant mutation profiling at single cell level is necessary. However, there are two major hurdles in the process. First, majority of the cells in tumor tissue are non-cancer cells and cause the prevailing noises. Second, the work load and cost of Next Generation Sequencing on dozens of single cells are prohibitive. To address these issues, we developed a microfluidic chip for dozens selected cells profiling. By the help of a novel tri-states valve structure which performing precise controlling of the cell/reagent movement, as well as active mixing of different reagents, trapping/identification/lysis and in situ MDA amplification was achieved at single cell level on the same chip. By a proof-of-concept assay mimicking EGFR targeting drug Gefitinib treatment of lung cancer cells, the new method was validated capable of not only detecting the existence of multiple mutations, but also providing complete information of the mutation scenario at single cell level by the use of cost-effective Sanger’s sequencing.

Back to tab navigation

Supplementary files

Publication details

The article was received on 29 Aug 2017, accepted on 23 Dec 2017 and first published on 09 Jan 2018

Article type: Paper
DOI: 10.1039/C7LC00924K
Citation: Lab Chip, 2018, Accepted Manuscript
  •   Request permissions

    Multiple Single Cell Screening and DNA MDA Amplification Chip for Oncogenic Mutation Profiling

    R. LI, M. Zhou, C. Yue, W. Zhang, Y. Ma, H. Peng, Z. Wei and Z. Hu, Lab Chip, 2018, Accepted Manuscript , DOI: 10.1039/C7LC00924K

Search articles by author